Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Pembrolizumab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Keytruda 100mg/4ml concentrate for inf vials
0801050CABBABAB
|
Keytruda | Pembrolizumab | Malignant Disease and Immunosuppression | No data available |
|
Keytruda 50mg pdr for concentrate for inf vials
0801050CABBAAAA
|
Keytruda | Pembrolizumab | Malignant Disease and Immunosuppression | No data available |
|
Pembrolizumab 100mg/4ml solution for infusion vials
0801050CAAAABAB
|
Pembrolizumab | Pembrolizumab | Malignant Disease and Immunosuppression | No data available |
|
Pembrolizumab 50mg powder for solution for infusion vials
0801050CAAAAAAA
|
Pembrolizumab | Pembrolizumab | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.